Supriya Lifescience Limited (SUPRIYA) — Cash Flow Quality Index
Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Quality Index of 0.65x as of September 2025. Operating cash flow of Rs555.65 Million is below net income of Rs852.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Supriya Lifescience Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Supriya Lifescience Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Supriya Lifescience Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Supriya Lifescience Limited (SUPRIYA) cash conversion ratio.
Annual Cash Flow Quality Index for Supriya Lifescience Limited (2018–2025)
Year-by-year earnings quality comparison for Supriya Lifescience Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | Rs1.73 Billion | Rs1.88 Billion | ▼ -3.5% |
| 2024 | 0.95x | Rs1.13 Billion | Rs1.19 Billion | ▲ +77.5% |
| 2023 | 0.54x | Rs661.87 Million | Rs1.23 Billion | ▲ +127.6% |
| 2022 | 0.24x | Rs488.01 Million | Rs2.07 Billion | ▼ -50.7% |
| 2021 | 0.48x | Rs799.30 Million | Rs1.67 Billion | ▼ -60.4% |
| 2020 | 1.21x | Rs1.16 Billion | Rs962.27 Million | ▲ +41.5% |
| 2019 | 0.85x | Rs486.72 Million | Rs571.04 Million | ▼ -57.4% |
| 2018 | 2.00x | Rs174.52 Million | Rs87.28 Million | — |